Maintenance: On Thursday, June 28 2018, 18:00-18:15, maintenance work on the ZORA servers is scheduled. ZORA will not be available during this period. Thank you for your patience.
Ademi, Zanfina; Pfeil, Alena M; Hancock, Elizabeth; Trueman, David; Haroun, Rola Haroun; Deschaseaux, Celine; Schwenkglenks, Matthias (2017). Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Swiss Medical Weekly:147:w14533.
Ademi, Zanfina; Sutherland, C Simone; Van Stiphout, Joris; Michaud, Jöelle; Tanackovic, Goranka; Schwenkglenks, Matthias (2017). A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives. Journal of Thrombosis and Thrombolysis, 44(4):494-506.
Blank, Patricia R; Ademi, Zanfina; Lu, Xiaoyan; Szucs, Thomas D; Schwenkglenks, Matthias (2017). Herpes zoster vaccine: A health economic evaluation for Switzerland. Human Vaccines & Immunotherapeutics, 13(7):1495-1504.
Ademi, Zanfina; Gloy, Viktoria; Glinz, Dominik; Raatz, Heike; Van Stiphout, Joris; Bucher, Heiner C; Schwenkglenks, Matthias (2016). Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss Medical Weekly, 146:w14382.
Gutzwiller, Florian S; Pfeil, Alena M; Ademi, Zanfina; Blank, Patricia R; Braunhofer, Peter G; Szucs, Thomas D; Schwenkglenks, Matthias (2015). Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. Pharmacoeconomics, 33(12):1311-1324.